Predictive Factors of Pseudoprogression in Vestibular Schwannoma Treated with Fractionated Stereotactic Radiotherapy

被引:0
|
作者
Lo, A. W. S. [1 ]
Nyaw, S. F. [2 ]
Mui, W. H. [2 ]
Huang, J. J. [2 ]
Kam, K. M. [3 ]
Wong, C. S. [2 ]
机构
[1] Prince Wales Hosp, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China
[2] Tuen Mun Hosp, Dept Clin Oncol, Tuen Mun, Hong Kong, Peoples R China
[3] Hong Kong Sanat & Hosp, Comprehens Oncol Ctr, Happy Valley, Hong Kong, Peoples R China
来源
HONG KONG JOURNAL OF RADIOLOGY | 2019年 / 22卷 / 03期
关键词
Neuroma; acoustic; Radiotherapy; Risk factors; ACOUSTIC NEUROMAS; RADIOSURGERY; RADIATION; MANAGEMENT; EXPANSION; SURGERY;
D O I
10.12809/hkjr1916934
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective: Fractionated stereotactic radiotherapy (FSRT) is a well-established treatment for vestibular schwannoma (VS). Tumour pseudoprogression may lead to worsening symptoms leading to the necessity of urgent salvage surgery. This study aimed to assess the predictive factors of pseudoprogression and treatment related toxicities in VS treated with FSRT. Methods: This retrospective cohort study included all patients with VS treated with FSRT between 1999 and 2015. Risk factors assessed included sex, age, previous surgical resection, tumour diameter, gross tumour volume, planning target volume, overall treatment time, equivalent dose in 2-Gy fractions, and the presence of brainstem or cerebellar compression prior to radiotherapy. Fisher's exact test and two-sample t test were used for statistical analysis. Results: Eighteen patients were included. The median follow-up time was 80.3 months. The overall disease control rate after FSRT was 94.4%. Of the 18 patients, one (5.6%) developed local tumour progression, seven (38.9%) underwent tumour pseudoprogression; and 10 (55.6%) had stable disease. Median time to tumour pseudoprogression was 8.63 months (range, 4.5-13.1 months). Tumours with pseudoprogression and those with at least stable disease had a mean diameter of 2.7 cm and 2.1 cm, respectively (p = 0.18). The mean treatment planning target volume in the pseudoprogression group was larger than that in the non-progression group with volume measured (22.2 cc vs. 10.0 cc; p = 0.04). Patients with brainstem or cerebellar compression observed on magnetic resonance imaging before radiotherapy were associated with a higher risk of pseudoprogression (p = 0.0498). The overall salvage surgery rate was 17.7%. Conclusion: Upfront surgery may be more desirable than FSRT for those surgically fit patients with considerable treatment volume and evidence of mass effect. Large prospective studies are needed to confirm our findings and to identify further predictive factors for pseudoprogression.
引用
收藏
页码:152 / 159
页数:8
相关论文
共 50 条
  • [31] Enlargement of a vestibular schwannoma after stereotactic radiotherapy
    Couldwell, WT
    Mohan, AL
    ACTA NEUROCHIRURGICA, 2002, 144 (12) : 1319 - 1322
  • [32] Enlargement of a Vestibular Schwannoma after Stereotactic Radiotherapy
    W. T. Couldwell
    A. L. Mohan
    Acta Neurochirurgica, 2002, 144 : 1319 - 1322
  • [33] Fractionated stereotactic radiotherapy for the treatment of vestibular schwannomas
    Jerome, J
    Goel, P
    Dickey, P
    Goodrich, P
    Sinha, RN
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S273 - S274
  • [34] Outcomes of Stereotactic Radiosurgery and Stereotactic Radiotherapy for the Treatment of Vestibular Schwannoma
    Choy, Winward
    Spasic, Marko
    Pezeshkian, Patrick
    Fong, Brendan M.
    Nagasawa, Daniel T.
    Trang, Andy
    Mathur, Ishani
    De Salles, Antonio
    Gorgulho, Alessandra
    Selch, Michael
    Gopen, Quinton S.
    Yang, Isaac
    NEUROSURGERY, 2013, 60 : 120 - 125
  • [35] Stereotactic radiosurgery vs. fractionated radiotherapy for tumor control in vestibular schwannoma patients: a systematic review
    Oscar Persson
    Jiri Bartek
    Netanel Ben Shalom
    Theresa Wangerid
    Asgeir Store Jakola
    Petter Förander
    Acta Neurochirurgica, 2017, 159 : 1013 - 1021
  • [36] Stereotactic radiosurgery vs. fractionated radiotherapy for tumor control in vestibular schwannoma patients: a systematic review
    Persson, Oscar
    Bartek, Jiri, Jr.
    Ben Shalom, Netanel
    Wangerid, Theresa
    Jakola, Asgeir Store
    Forander, Petter
    ACTA NEUROCHIRURGICA, 2017, 159 (06) : 1013 - 1021
  • [38] 3D quantitative assessment of response to fractionated stereotactic radiotherapy and single-session stereotactic radiosurgery of vestibular schwannoma
    Schneider, T.
    Chapiro, J.
    Lin, M.
    Geschwind, J. F.
    Kleinberg, L.
    Rigamonti, D.
    Jusue-Torres, I.
    Marciscano, A. E.
    Yousem, D. M.
    EUROPEAN RADIOLOGY, 2016, 26 (03) : 849 - 857
  • [39] 3D quantitative assessment of response to fractionated stereotactic radiotherapy and single-session stereotactic radiosurgery of vestibular schwannoma
    T. Schneider
    J. Chapiro
    M. Lin
    J. F. Geschwind
    L. Kleinberg
    D. Rigamonti
    I. Jusué-Torres
    A. E. Marciscano
    D. M. Yousem
    European Radiology, 2016, 26 : 849 - 857
  • [40] Audiological assessment before and after fractionated stereotactic irradiation for vestibular schwannoma
    Sakamoto, T
    Shirato, H
    Sato, N
    Kagei, K
    Sawamura, Y
    Suzuki, K
    Takizawa, H
    Hokunan, K
    Isu, T
    Fukuda, S
    Inuyama, Y
    Miyasaka, K
    RADIOTHERAPY AND ONCOLOGY, 1998, 49 (02) : 185 - 190